Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 70INDUSTRY 40NIH 12NETWORK 5OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 3Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 1

Interventions

Irinotecan 11Oxaliplatin 8Cetuximab 7Fluorouracil 6Leucovorin 5Bevacizumab 5Standard of Care 4S 1 (combination) 4Capecitabine 4trifluridine tipiracil drug combination 2tislelizumab 2apatinib 2Propranolol 2Preoperative Exercise 2Panitumumab 2Levoleucovorin 2Folfox protocol 2Etodolac 2Endoscopic Mucosal Resection 2Drug Therapy 2Chemotherapy, Adjuvant 2trebananib 1regorafenib 1envafolimab 1Trifluridine 1Thalidomide 1Surveys and Questionnaires 1Occult Blood 1Neoadjuvant Therapy 1Moxibustion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Colorectal Neoplasms × Folfox protocol × Clear all
NCT03940131 2022-04-06

REPAN

King Abdullah Medical City

Phase 2 Unknown
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00070213 2021-09-27

Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Medical Research Council

Phase 3 Completed
460 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡